click below
click below
Normal Size Small Size show me how
DM-Naloxone
| Question | Answer |
|---|---|
| Class | Narcotic antagonist |
| Action | Competes for opioid receptor sites. Displaces previously administered opioids from their receptors. No pharmacological activity on its own. |
| Indications | Decreased level of responsiveness Respiratory depression - (Requiring BVM) Signs and symptoms: Suggestive of narcotic overdose (pinpoint pupils, drug paraphernalia, track marks, pill bottles etc.) |
| Contraindications | Allergy, Neonate |
| Cautions | Acute Withdrawal Symptoms/Aggression |
| Side Effects | CNS - Excitation due to abrupt reversal of analgesia CVS – Tachycardia, hypertension, hypotension, arrhythmias Skin – Sweating |
| Dosage | IN - Delivered Q 3 minutes in the following order until LOC and/or RR improve: 2.0mg, 2.0mg, and 2.0mg IM - Delivered Q 3 minutes in the following order until LOC and/or RR improve: 0.4mg, 0.4mg, 0.8mg and 2.0mg |
| Route | IM, IN |
| Onset, Peak, Duration | Onset: 3-5 minutes Peak: Unknown Duration: 45 minutes |
| Special Considerations | Can cause abrupt state of narcotic withdrawal in the physically dependent patient Side effects such as agitation and aggressiveness can be symptoms of narcotic withdrawal |
| What can happen later to a patient after adminstering naloxone and their condition improves? In regards to the opioid drugs they have taken? | Naloxone’s half-life is shorter than that of all opioids; therefore, a patient must be observed until the narcotic effect has worn off |